HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Propranolol and periocular capillary hemangiomas: assessment of refractive effect.

AbstractPURPOSE:
To assess the effects of systemic propranolol on refractive error in infants with periocular capillary hemangiomas.
METHODS:
A single-center study of consecutive patients with capillary hemangiomas treated with systemic propranolol. Refractive data were analyzed using Long's matrix formalism and the methods of Harris and Kaye.
RESULTS:
Seventeen patients were included. At 6 months postoperatively, hemangioma size reduced from 3,214 to 1,806 mm(3) (standard deviation: 4,122 to 2,441). Mean refractive error in the affected eye significantly reduced: -1.25/0.38 × 36 (95% confidence intervals: -5.08/1.20 × 90 to 1.64/1.43 × 180, P = .048) with a smaller change (P = .06) in the unaffected eye of -1.01/+0.31 × 3.16 (95% confidence intervals: -4.02/+1.12 × 180 to +1.49/+0.51 × 90).
CONCLUSIONS:
Propranolol produced a clinically significant reduction in the infants' refractive error and anisometropia. The reduction in the total refractive error and anisometropia has not been evident in previous analyses, which have concentrated on the change in the "cylinder" as the principal outcome measure.
AuthorsPeter Glasman, Arvind Chandna, Harish Nayak, Simran Mangat, Stephen Kaye
JournalJournal of pediatric ophthalmology and strabismus (J Pediatr Ophthalmol Strabismus) 2014 May-Jun Vol. 51 Issue 3 Pg. 165-70 ISSN: 1938-2405 [Electronic] United States
PMID24877527 (Publication Type: Journal Article)
CopyrightCopyright 2014, SLACK Incorporated.
Chemical References
  • Adrenergic beta-Antagonists
  • Propranolol
Topics
  • Adrenergic beta-Antagonists (administration & dosage)
  • Astigmatism
  • Child, Preschool
  • Eye Neoplasms (drug therapy, physiopathology)
  • Female
  • Hemangioma, Capillary (drug therapy, physiopathology)
  • Humans
  • Male
  • Propranolol (administration & dosage)
  • Refraction, Ocular (physiology)
  • Refractive Errors (physiopathology)
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: